AIM · AIM ImmunoTech Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Nov 12, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-10 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
39,000 |
| 2026-11-09 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
31,298 |
| 2026-11-06 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
12,751 |
| 2026-11-06 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
20,299 |
| 2026-10-23 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
31,675 |
| 2026-10-22 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
31,250 |
| 2026-09-17 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
24,000 |
| 2026-09-16 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
11,000 |
| 2026-09-15 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
22,000 |
| 2026-09-14 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
5,900 |
| 2026-03-12 | Equels Thomas K |
Director, CEO & President |
Other↑
|
Common stock
|
25,000 |
| 2026-03-12 | Equels Thomas K |
Director, CEO & President |
Other↓
Filing footnotes — Series G Convertible Preferred Stock (Direct)
The Preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole perferred share, effectively $1.00 per share of common stock. None |
Series G Convertible Preferred Stock
|
25 |
| 2026-03-12 | CHEMEROW DAVID I. |
Director |
Other↑
|
Common Stock
|
25,000 |
| 2026-03-12 | CHEMEROW DAVID I. |
Director |
Other↓
Filing footnotes — Series G Convertible Prefered Stock (Direct)
The preferred shares are convertible into common stock at a rate of 1,000 shares of common stock per whole preferred share, effectively $1.00 per share of common stock. None |
Series G Convertible Prefered Stock
|
25 |
| 2026-03-06 | Equels Thomas K |
Director, CEO & President |
Other↑
Filing footnotes — Series G Convertible Preferred Stock (Direct)
Each share has a stated value of $1,000 and is convertible into 1,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. n/a - Preferred shares are perpetual. |
Series G Convertible Preferred Stock
|
25 |
| 2026-03-06 | Equels Thomas K |
Director, CEO & President |
Other↑
Filing footnotes — Class G Warrants (Direct)
Each warrant is exercisable for one share of common stock at an exercise price of $1.00 per share and was issued as part of a subscription right issued in a rights offering. |
Class G Warrants
|
50,000 |
| 2026-03-06 | CHEMEROW DAVID I. |
Director |
Other↑
Filing footnotes — Class G Warrants (Direct)
Each warrant is exercisable for one share of common stock at an exercise price of $1.00 per share and was issued as part of a subscription right issued in a rights offering. |
Class G Warrants
|
50,000 |
| 2026-03-06 | CHEMEROW DAVID I. |
Director |
Other↑
Filing footnotes — Series G Convertible Preferred Stock (Direct)
Each share has a stated value of $1,000 and is convertible into 1,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. n/a - Preferred shares are perpetual. |
Series G Convertible Preferred Stock
|
25 |
| 2026-02-05 | CHEMEROW DAVID I. |
Director |
Award↑
|
Common Stock
(I)
|
2,800 |
| 2025-06-13 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
107 |
| 2025-06-12 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
103 |
| 2025-04-11 | MITCHELL WILLIAM M |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
196,851 |
| 2025-04-11 | KELLNER TED D |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
1,968,504 |
| 2025-04-11 | Equels Thomas K |
Director, CEO & President |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
Common Stock
|
1,968,504 |
| 2025-04-04 | Rodino Peter W III |
COO, Secretary, Gen. Counsel |
Buy↑
|
Common Stock
|
500 |
| 2025-04-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
41,000 |
| 2025-03-14 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-14 | CHEMEROW DAVID I. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-14 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
44,899 |
| 2025-03-05 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
50,000 |
| 2025-03-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
83,334 |
| 2025-03-04 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
44,000 |
| 2025-02-28 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
38,580 |
| 2025-02-28 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
38,580 |
| 2025-02-28 | CHEMEROW DAVID I. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
19,290 |
| 2025-02-14 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
43,330 |
| 2025-02-14 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
43,330 |
| 2025-01-31 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
25,797 |
| 2025-01-31 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
25,797 |
| 2025-01-15 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
27,412 |
| 2025-01-15 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
27,412 |
| 2024-12-31 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
26,305 |
| 2024-12-31 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
26,305 |
| 2024-12-31 | APPELROUTH STEWART |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
8,768 |
| 2024-12-19 | MITCHELL WILLIAM M |
Director |
Sell↓
|
Common Stock
|
4,580 |
| 2024-12-18 | Equels Thomas K |
Director, CEO & President |
Buy↑
|
Common Stock
|
22,727 |
| 2024-12-13 | APPELROUTH STEWART |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-13 | BRYAN NANCY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-13 | MITCHELL WILLIAM M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Common Stock
|
24,452 |
| 2024-12-02 | APPELROUTH STEWART |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The reporting person did not intend this purchase. |
Common Stock
|
1 |